NCT06567483View on ClinicalTrials.gov

A Comparison of Protein-bound and Large Molecular Weight Uremic Toxin Removals With Novel Super High-flux Dialyzer Between Hemodialysis and High Volume Online HDF Modalities

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions
Uremic; Toxemia
Interventions
DEVICE

ELISIO21HX

Super-high flux dialyzers (ELISIO21HX) will be used. The blood flow rate and dialysate flow rate will be set as 400 and 800 ml/min respectively for 4 hours of dialysis.

Trial Locations (1)

10330

Faculty of Medicine Chulalongkorn university, Pathum Wan

All Listed Sponsors
lead

Chulalongkorn University

OTHER

NCT06567483 - A Comparison of Protein-bound and Large Molecular Weight Uremic Toxin Removals With Novel Super High-flux Dialyzer Between Hemodialysis and High Volume Online HDF Modalities | Biotech Hunter | Biotech Hunter